Sort
30,917 grants matching “tumor microenvironment”
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$452,277Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2021 · CA
Targeting the DNA damage response in combination with radiation to induce innate immunity and improve immunotherapy efficacy in pancreatic cancer
$452,277Meredith A Morgan · University Of Michigan At Ann Arbor · R01 · FY2020 · CA
Genomics and Computational Biology Shared Resource
$452,240Kelly A Frazer · University Of California, San Diego · P30 · FY2023 · CA
Mathematical Model-Guided Adoptive Immunotherapy in Bladder Cancer
$452,237Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium
$452,195Robert M Straubinger · State University Of New York At Buffalo · R01 · FY2015 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2022 · CA
Vaccine Targeting of RCC Blood Vessels to Promote TME Normalization and Enhance TIL Recruitment
$452,135Walter J Storkus · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · CA
Hypoxia-derived molecular MSI signatures to predict breast cancer outcome
$452,109Kristine Glunde · Johns Hopkins University · R01 · FY2017 · CA
Epigenetic Regulation of Head and Neck Cancer Immune Evasion
$452,097Chao Lu · Columbia University Health Sciences · R01 · FY2022 · DE
Epithelial cell complement production in the pathogenesis of chronic rhinosinusitis
$452,090Jennifer Konopa Mulligan · University Of Florida · R01 · FY2025 · AI
Ontogeny and Function of Tumor-associated Macrophages
$452,082Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2019 · CA
Genomics and Computational Biology Shared Resource
$452,002Kelly A Frazer · University Of California, San Diego · P30 · FY2021 · CA
The role of the senescent microenvironment on cancer initiating cells in the colon.
$451,960William M Grady · Fred Hutchinson Cancer Research Center · U01 · FY2021 · AG
Improving anti-tumor immunity in advanced breast cancer by targeting solid stress
$451,940Dennis Jones · Boston University Medical Campus · R01 · FY2024 · CA
Intersections of RNA-binding proteins and T-cells in oral epithelial plasticity
$451,881Viswanathan Palanisamy · Medical University Of South Carolina · R01 · FY2022 · DE
Mechanisms of cytokine driven tumor elicited inflammation in colorectal cancer
$451,870Sergei I Grivennikov · Cedars-Sinai Medical Center · R01 · FY2022 · CA
Lymphoid Experimental Therapeutics Platform to Study Cooperative Signaling inHuman Lymphomas
$451,764Ankur Singh · Georgia Institute Of Technology · R01 · FY2022 · CA
The roles of a unique GTP-binding protein/crosslinking enzyme in disease
$451,697Richard A. Cerione · Cornell University · R01 · FY2019 · CA
Cell of Origin and the Roles of Tumor Microenvironment in Neurofibroma Development and Therapeutics
$451,616Lu Le · Ut Southwestern Medical Center · R01 · FY2020 · CA
STING-dependent activation of Natural Killer cells by viral and tumor DNA
$451,602David H Raulet · University Of California Berkeley · R01 · FY2021 · AI
Impact of cancer predisposition on oncogenic process, microenvironment, and treatment
$451,596Li Ding · Washington University · R01 · FY2024 · CA
Role of prolactin in adipocyte-breast cancer cell crosstalk
$451,500Maria Diakonova · University Of Toledo · R15 · FY2022 · CA
Role of CREBBP missense mutations in lymphomagenesis
$451,334Laura Pasqualucci · Columbia University Health Sciences · R01 · FY2024 · CA
Modeling immunity with a hybrid lymph node tissue-chip
$451,321Rebecca R Pompano · University Of Virginia · R01 · FY2021 · AI
Defining pro-metastatic drivers in the pancreatic cancer tumor microenvironment
$451,313Michael Paul Kim · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA